Top 5 Physical Rehabilitation Apps for Primary Care Providers

Weekly Dose Podcast: FDA Breakthrough in Acromegaly, Alcohol–Dementia Risk Clarified, Tirzepatide in Youth T2D, Precision Mood Gains, and Major Contraception Practice Insights

Clevenger speaks to primary care clinicians, emphasizing 3 priorities: engage family as partners, ask about agitation, and recognize its danger to patient and caregiver.

November 19th 2025

Weekly Dose Podcast: New AD Blood Test, Elinzanetant’s Sleep Effects, Lung Cancer Screening Success, Menopause Symptom Burden, and VMS Treatment Approval

Topics include new findings on oral acromegaly therapy, alcohol and dementia risk, tirzepatide in youth T2D, precision mood care, and LARC outcomes.

Weekly Dose Podcast: New Insights on Colonoscopy Adherence, rt-CGM in GDM, Semaglutide Effects, Parent Vaccine Views, and MI Causes

Episode highlights include a new AD blood test for PCPs, sleep effects of elinzanetant among postmenopausal women, lung cancer screening gains, and more.

November 13th 2025

Routine Alcohol Screening Scores Linked to Mortality Risk in Primary Care Patients

Topics include rideshare support for colonoscopy, rt-CGM benefits in GDM, semaglutide and food noise, vaccine views, and MI etiology.

FDA Opens Safety Review of RSV Monoclonal Antibodies Used in Infants

A cohort study of 531 851 primary care patients found routine AUDIT-C alcohol screening scores predict 8-year all-cause mortality, with strongest effects in younger adults.

Grace Halsey

Agitation in Alzheimer Disease: Proactive Assessment and Caregivers' Roles with Carolyn Clevenger, GNP

The inquiry follows internal requests for closer review of trial findings and real-world evidence; regulators have not yet indicated any planned actions.

Related Content

Carolyn Clevenger, GNP;Grace Halsey

Weekly Dose Podcast: FDA Breakthrough in Acromegaly, Alcohol–Dementia Risk Clarified, Tirzepatide in Youth T2D, Precision Mood Gains, and Major Contraception Practice Insights

Clevenger speaks to primary care clinicians, emphasizing 3 priorities: engage family as partners, ask about agitation, and recognize its danger to patient and caregiver.

November 19th 2025

Weekly Dose Podcast: New AD Blood Test, Elinzanetant’s Sleep Effects, Lung Cancer Screening Success, Menopause Symptom Burden, and VMS Treatment Approval

Topics include new findings on oral acromegaly therapy, alcohol and dementia risk, tirzepatide in youth T2D, precision mood care, and LARC outcomes.

Weekly Dose Podcast: New Insights on Colonoscopy Adherence, rt-CGM in GDM, Semaglutide Effects, Parent Vaccine Views, and MI Causes

Episode highlights include a new AD blood test for PCPs, sleep effects of elinzanetant among postmenopausal women, lung cancer screening gains, and more.

November 13th 2025

Routine Alcohol Screening Scores Linked to Mortality Risk in Primary Care Patients

Topics include rideshare support for colonoscopy, rt-CGM benefits in GDM, semaglutide and food noise, vaccine views, and MI etiology.

FDA Opens Safety Review of RSV Monoclonal Antibodies Used in Infants

A cohort study of 531 851 primary care patients found routine AUDIT-C alcohol screening scores predict 8-year all-cause mortality, with strongest effects in younger adults.

Grace Halsey